IDiyas

For the Inventor, By the Inventor

Bridgewater, NJ, United States of America

Scott Christian Mayer

USPTO Granted Patents = 21

 

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 104(Granted Patents)


Location History:

  • Robbinsville, NJ (US) (2001 - 2009)
  • Bridgewater, NJ (US) (2003 - 2010)

Company Filing History:

goldMedal19 out of 1,309 
 
Wyeth
 patents
silverMedal1 out of 1,567 
 
American Home Products Corporation
 patents
bronzeMedal1 out of 832,680 
Other
 patents

Years Active: 2001-2010

Loading Chart...
Loading Chart...
21 patents (USPTO):
1. 7858658 - Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof (2010-12-28),
2. 7713994 - [object Object] (2010-05-11),
3. 7629377 - Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) (2009-12-08),
4. 7550629 - Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors (2009-06-23),
5. 7547725 - Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof (2009-06-16),
6. 7514411 - Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation (2009-04-07),
7. 7446201 - Substituted heteroaryl benzofuran acids (2008-11-04),
8. 7351730 - Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) (2008-04-01),
9. 7300951 - Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof (2007-11-27),
10. 7132402 - Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation (2006-11-07),
11. 7081448 - Benzyllactobionamides as inhibitors of smooth muscle cell proliferation (2006-07-25),
12. 7008636 - 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia (2006-03-07),
13. 6939886 - Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) (2005-09-06),
14. 6849761 - Substituted naphthoic acid derivatives useful in the treatment of insulin resistance and hyperglycemia (2005-02-01),
15. 6800654 - Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) (2004-10-05),

Title: The Innovative Journey of Scott Christian Mayer

Introduction:

Scott Christian Mayer, a visionary inventor based in Bridgewater, NJ, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents:

Scott Christian Mayer's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights:

With a background in engineering and a passion for innovation, Scott Christian Mayer has successfully brought several inventions from concept to reality. His ability to think outside the box and solve complex problems has set him apart in the industry.

Collaborations:

Throughout his career, Scott Christian Mayer has collaborated with leading research institutions and tech companies to further develop his inventions. His collaborative spirit and dedication to excellence have led to successful partnerships and groundbreaking innovations.

Conclusion:

In conclusion, Scott Christian Mayer's relentless pursuit of innovation and commitment to pushing the boundaries of technology make him a true pioneer in the field of inventions. His impact on the industry is profound, and his legacy as an inventor continues to inspire future generations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…